Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Triumvira
Triumvira
Triumvira is Creating a Different Picture for Cancer Patients
BioSpace
Wed, 09/22/21 - 11:36 pm
Triumvira
CAR-T
cancer
solid tumors
Triumvira Immunologics raises $55M in Series A funding round for new form of cancer cell therapy
MedCity News
Sun, 08/30/20 - 11:22 pm
Triumvira
Bayer
clinical trials
cell therapy
cancer
Triumvira snags $55M Series A to guide TAC technology to the clinic
Endpoints
Thu, 08/27/20 - 10:47 am
Triumvira
TAC
immunologics
Triumvira Submits IND Application to the FDA and CTA to Health Canada to Evaluate Immuno-Oncology Candidate
CP Wire
Wed, 05/1/19 - 10:29 am
Triumvira
TAC01-CD19
immuno-oncology
FDA
Health Canada
Triumvira Submits IND Application to the FDA and CTA to Health Canada to Evaluate Immuno-Oncology Candidate
Wed, 05/1/19 - 09:54 am
Triumvira
TAC01-CD19
immuno-oncology